European Market Report for Port Needles 2017 - MedCore - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "European Market Report for Port Needles 2017 - MedCore" report to their offering.

Over the forecast period, the total port needle market is expected to experience growth. The increase in market value will be driven by growth in the size and age of the European population and the corresponding rise in demand for cancer treatment.

Growth will be limited by ASP erosion. Price declines will be driven by competition amongst firms and a lack of technological innovation. Price erosion will be limited by growth in the alternate care market as well as the conversion to safety port needles.

Port needles or Huber needles are used exclusively for accessing implantable ports; therefore, there is a strong correlation between the sales of these two devices.

While ports are primarily implanted in hospitals, port needles are widely used in alternate care sites. Improved designs of port needles are allowing patients to refill and maintain their implantable ports on their own or with minimal help from family or clinical staff. However, many port patients must visit a hospital to receive treatment because they require monitoring or assistance, particularly if their medication has potential side effects.

Key Topics Covered:

Table Of Contents I

List Of Figures Xvi

List Of Charts Xx

Executive Summary

European Market For Vascular Access Devices And Accessories Overview

Competitive Analysis

Market Trends

Market Developments

Procedure Numbers

Markets Included

Key Report Updates

Version History

Research Methodology

Companies Mentioned

3DT Holdings LLC

3M

Access Scientific

Ambu Inc.

AngioDynamics

Artsana

Cardinal Health

CareFusion

Codan

Cook Medical

Covidien

Deltamed

Districlass Medical

Edwards Lifesciences

Medcomp

Medikit

Medtronic

Navilyst Medical

Nipro Medical

Nostix, LLC

Novico

Pentaferte

SonoSite, Inc.

Teleflex Medical

Terumo

Troge

Vascular Pathways, Inc.

VeriTeQ Acquisition Corp.

VigMed

V-Tech

Vygon

For more information about this report visit http://www.researchandmarkets.com/research/qh67w3/european_market

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infusions and Injectables, Needles and Syringes

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infusions and Injectables, Needles and Syringes